DEVICE #1 4870-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 02,05,06 report with the FDA on 1997-01-17 for DEVICE #1 4870-26 manufactured by Smiths Industries Medical Systems.

Event Text Entries

[15449078] The pt underwent the cvs procedure at 11 weeks gestation. Two transcervical passes were made. Intrauterine fetal demise was found at 15 weeks gestation and was estimated based on fetal size, to have occurred between 10-12 weeks gestation. A d&c was performed. The pathology report states that the fetus was masserated, partially dehydrated and the umbilical cord was wrapped twice around the neck. A d&c was performed.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1217052-1997-00006
MDR Report Key62758
Report Source02,05,06
Date Received1997-01-17
Date of Report1996-12-18
Date of Event1995-12-04
Date Mfgr Received1996-12-18
Device Manufacturer Date1995-08-01
Date Added to Maude1997-01-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDEVICE #1
Generic NameCATHETER, SAMPLING, CHORNIC VILLUS
Product CodeLLX
Date Received1997-01-17
Model NumberNA
Catalog Number4870-26
Lot Number508582
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNO INFO
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key63007
ManufacturerSMITHS INDUSTRIES MEDICAL SYSTEMS
Manufacturer Address15 KIT ST KEENE NH 03431 US
Baseline Brand NameTROPHOCAN CVS CATHETER
Baseline Generic NameCATHETER, SAMPLING, CHORIONIC VILLUS
Baseline Model NoNA
Baseline Catalog No4870-26
Baseline IDNA
Baseline Device FamilyNA
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]60
Baseline PMA FlagY
Premarket ApprovalP8900
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1997-01-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.